INTERFACE BIOLOGICS, INC. (IBI) is a privately held early commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.
Total raised: $8M
Founded date: 2001
Investors 3
| Date | Name | Website |
| - | DSM | dsm.com |
| - | DSM Ventur... | venturing.... |
| - | BDC | bdc.ca/ |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 08.12.2011 | - | $1M | - | finsmes.co... |
| 10.01.2011 | Series B | $7M | - | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 08.12.2011 | Interface ... | Interface Biologics, a Toronto... | Canada fu... | - | finsmes.co... |
| 10.01.2011 | Interface ... | Interface Biologics, Inc., a T... | Canada fu... | - | finsmes.co... |